Article

Multiple expression assessments of ACE2 and TMPRSS2 SARS-CoV-2 entry molecules in the urinary tract and their associations with clinical manifestations of COVID-19

2020-05-08

Abstract excerpt

<h4>Background</h4> Since December 2019, the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first spread quickly in Wuhan, China, then globally. From previously published evidence, ACE2 and TMPRSS2, are both pivotal entry molecules that enable cellular infection by SARS-CoV-2. Meanwhile, increased expression of pro-inflammatory cytokines, or a “cytokine storm,” is associated with...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e19dede9-c159-5731-97fb-478f20949711
DOI: 10.1101/2020.05.08.083618

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Multiple expression assessments of ACE2 and TMPRSS2 SARS-CoV-2 entry molecules in the urinary tract and their associations with clinical manifestations of COVID-19DOI 10.1101/2020.05.08.083618Read

Multiple Expression Assessments of ACE2 and TMPRSS2 SARS-CoV-2 Entry Molecules in the Urinary Tract and Their Associations with Clinical Manifestations of COVID-19Semantic proximity Read

ACE2 Expression in Kidney and Testis May Cause Kidney and Testis Infection in COVID-19 PatientsSemantic proximity Read

The scRNA-seq Expression Profiling of the Receptor ACE2 and the Cellular Protease TMPRSS2 Reveals Human Organs Susceptible to SARS-CoV-2 Infection.Semantic proximity Read

The scRNA-seq expression profiling of the receptor ACE2 and the cellular protease TMPRSS2 reveals human organs susceptible to COVID-19 infectionSemantic proximity Read

The protein expression profile of ACE2 in human tissuesSemantic proximity Read

scRNA-seq Profiling of Human Testes Reveals the Presence of ACE2 Receptor, a Target for SARS-CoV-2 Infection, in Spermatogonia, Leydig and Sertoli CellsSemantic proximity Read

scRNA-seq Profiling of Human Testes Reveals the Presence of the ACE2 Receptor, A Target for SARS-CoV-2 Infection in Spermatogonia, Leydig and Sertoli CellsSemantic proximity Read

Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2Semantic proximity Read

Identifying pathways and networks associated with the SARS-CoV-2 cell receptor ACE2 based on gene expression profiles in human tissuesSemantic proximity Read

Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2Semantic proximity Read

A computational and bioinformatic analysis of ACE2: an elucidation of its dual role in COVID-19 pathology and finding its associated partners as potential therapeutic targetsSemantic proximity Read

Sex differences in viral entry protein expression and host transcript responses to SARS-CoV-2Semantic proximity Read